Anteris Technologies Global Corp. AVR 深 滬
等待開盤 06-10 09:30:00 美东时间
9.47
+0.130
+1.39%
華盛通- 最 高9.65
- 今 開9.52
- 成交量 169.65万股
- 最 低 8.85
- 昨 收 9.34
- 總市值 9.22亿
- 52周最高 10.14
- 市盈率 靜 --
- 換手率 1.74%
- 52周最低 2.85
- 委 比 -79.34%
- 總股本 9734.22万
- 歷史最高 10.14
- 量 比 1.30
- 振 幅 8.57%
- 歷史最低 2.34
- 每 手 1
- 風險率 1.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Anteris wins French ANSM clearance for DurAVR transcatheter valve PARADIGM trial
Anteris wins French ANSM clearance for DurAVR transcatheter valve PARADIGM trial Anteris won full ANSM clearance in France for the DurAVR transcatheter heart valve PARADIGM global pivotal trial in severe calcific aortic stenosis. The authorization allows patient recruitment to start at French center
06-08 18:00
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Anteris Technologies Global Corp. has received regulatory approval from France's ANSM for its DurAVR® Transcatheter Heart Valve pivotal trial (PARADIGM Trial) in patients with severe calcific aortic stenosis, enabling patient recruitment to begin at leading French centers. The PARADIGM Trial, a randomized controlled study, will compare the safety and effectiveness of DurAVR® with existing TAVR devices in approximately 1,000 patients, assessing ou...
06-08 10:00
Anteris Director Susan Knight Buys First Stake in Company
The latest update is out from Anteris Technologies ( ($AU:AVR) ). Anteris Techn...
06-05 09:58
Anteris launches $250m at-the-market program to fund structural heart push
The latest update is out from Anteris Technologies ( ($AU:AVR) ). Anteris Techn...
05-25 07:13
Anteris Technologies Global To Offer Up To $250M Of Common Stock Through TD Cowen
https://www.sec.gov/ix?doc=/Archives/edgar/data/0002011514/000114036126022633/ny20074564x2_8k.htm
05-23 05:22
Anteris Technologies’ director Stephen Denaro files initial beneficial ownership statement
Anteris Technologies’ director Stephen Denaro files initial beneficial ownership statement Anteris Technologies Global filed a Form 3 showing director Stephen Denaro held 23,722 common shares indirectly as of May 11, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using g
05-19 18:06
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Barclays Maintains Overweight on Anteris Technologies Glb, Raises Price Target to $18
Barclays analyst Matt Miksic maintains Anteris Technologies Glb (NASDAQ:AVR) with a Overweight and raises the price target from $17 to $18.
05-15 21:55
Anteris appoints Susan Knight, Stephen Denaro to board
Anteris appoints Susan Knight, Stephen Denaro to board Anteris Technologies Global Corp. appointed Susan Knight, former board chair of medical device provider Surmodics, to its board as a Class I director with a term expiring at 2028 annual meeting. Knight previously served as senior vice president
05-13 20:39
Anteris Technologies Adds Experienced Financial Leaders to Board
Anteris Technologies Global Corp. ( ($AVR) ) just unveiled an update. On May 11...
05-13 18:44
